pdb_id,structure_name,organism,resolution,space_group,crystal_system,unit_cell_a,unit_cell_b,unit_cell_c,unit_cell_alpha,unit_cell_beta,unit_cell_gamma,crystal_method,crystal_ph,crystal_temp,matthews_coefficient,solvent_content,b_factor_mean,wilson_b_factor
5V39,Crystal structure of human vitamin D receptor ligand binding domain in complex with a VDRM,Homo sapiens,2.2,P 21 21 21,Orthorhombic,44.0,52.67,105.88,90.0,90.0,90.0,VAPOR DIFFUSION,,298.0,,41.53,,
6XZH,Structure of zVDR LBD-Calcitriol in complex with chimera 10,Danio rerio,2.372,P 65 2 2,Hexagonal,66.09,66.09,260.14,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,290.0,,47.05,,
6XZI,Structure of zVDR LBD-calcitriol in complex with chimera 11,Danio rerio,2.1,P 65 2 2,Hexagonal,66.35,66.35,262.37,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,290.0,,48.1,,
6XZJ,Structure of zVDR LBD-Calcitriol in complex with chimera 12,Danio rerio,2.1,P 65 2 2,Hexagonal,66.2,66.2,254.22,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,45.96,,
6XZK,Structure of zVDR LBD-Calcitriol in complex with chimera 13,Danio rerio,2.0,P 65 2 2,Hexagonal,66.112,66.112,262.488,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,290.0,,47.67,,
6XZV,Structure of zVDR LBD-Calcitriol in complex with chimera 18,Danio rerio,2.3,P 65 2 2,Hexagonal,66.244,66.244,252.522,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,290.0,,45.88,,
3B0T,Human VDR ligand binding domain in complex with maxacalcitol,Homo sapiens,1.3,P 21 21 21,Orthorhombic,45.013,51.377,132.121,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.6,,
7QPP,High resolution structure of human VDR ligand binding domain in complex with calcitriol,Homo sapiens,1.52,P 21 21 21,Orthorhombic,44.926,51.317,132.317,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,51.93,,
8PWD,Crystal structure of VDR in complex Des-C-Ring and Aromatic-D-Ring analog 3c,Danio rerio,2.8,P 65 2 2,Hexagonal,66.633,66.633,265.644,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,48.5,,
8PWE,Crystal structure of VDR complex with Novel Des-C-Ring and Aromatic-D-Ring analog 3a,Danio rerio,2.0,P 65 2 2,Hexagonal,65.8,65.8,263.387,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.73,,
8PWF,crystal structure of VDR in complex with Des-C-Ring and Aromatic-D-Ring analog 2,Danio rerio,2.3,P 65 2 2,Hexagonal,65.599,65.599,264.121,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.56,,
8PWM,Crystal structure of VDR in complex with Des-C-Ring and Aromatic-D-Ring analog 3b,Danio rerio,2.3,P 65 2 2,Hexagonal,65.849,65.849,264.213,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,57.47,,
8PZ6,"crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 analog 56",Danio rerio,2.9,P 65 2 2,Hexagonal,66.07,66.07,261.06,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.7,,
8PZ7,"crystal structure of VDR complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 57",Danio rerio,2.93,P 65 2 2,Hexagonal,66.24,66.24,264.04,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.99,,
8PZ8,"crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 54",Danio rerio,2.64,P 65 2 2,Hexagonal,65.37,65.37,262.01,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,56.51,,
8PZ9,"Crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 55",Danio rerio,2.74,P 65 2 2,Hexagonal,65.79,65.79,263.83,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.2,,
8PZB,"crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 49",Danio rerio,2.73,P 65 2 2,Hexagonal,65.62,65.62,263.62,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.49,,
9FW8,VDR complex with UG-650,Danio rerio,2.42,P 65 2 2,Hexagonal,66.01,66.01,264.2,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,290.0,,47.23,,
1S0Z,Crystal structure of the VDR LBD complexed to seocalcitol.,Homo sapiens,2.5,P 21 21 21,Orthorhombic,45.134,52.528,132.648,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.35,,
1S19,Crystal structure of VDR ligand binding domain complexed to calcipotriol.,Homo sapiens,2.1,P 21 21 21,Orthorhombic,45.248,52.55,132.909,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.58,,
4IA1,Diastereotopic and Deuterium Effects in Gemini,Danio rerio,2.44,P 65 2 2,Hexagonal,65.893,65.893,266.886,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.79,,
4IA2,Diastereotopic and Deuterium Effects in Gemini,Danio rerio,2.95,P 65 2 2,Hexagonal,65.77,65.77,266.421,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.5,,
4IA3,Diastereotopic and Deuterium Effects in Gemini,Danio rerio,2.7,P 65 2 2,Hexagonal,66.044,66.044,266.634,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.98,,
4IA7,Diastereotopic and Deuterium Effects in Gemini,Danio rerio,2.7,P 65 2 2,Hexagonal,66.178,66.178,266.412,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,48.15,,
5YSY,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2R,3R)-5-[(E)-2-{(1R,3aS,7aR)-1-[(R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl}vinyl]-2-(3-hydroxypropyl)cyclohex-4-ene-1,3-diol",Homo sapiens,2.0,P 21 21 21,Orthorhombic,44.682,51.538,132.651,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.37,,
5YT2,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2S,3R)-5-[(E)-2-{(1R,3aS,7aR)-1-[(R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl}vinyl]-2-(3-hydroxypropyl)cyclohex-4-ene-1,3-diol",Homo sapiens,2.0,P 21 21 21,Orthorhombic,44.565,51.565,132.49,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.22,,
9EZ1,"Vitamin D receptor in complex with 1,4a,25-trihydroxyvitamin D3",Danio rerio,1.95,P 65 2 2,Hexagonal,65.98,65.98,263.47,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.47,,
9EZ2,"Vitamin D receptor complex with 1,4b,25-trihydroxyvitamin D3",Danio rerio,1.8,P 65 2 2,Hexagonal,66.14,66.14,263.74,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.35,,
9GY8,Vitamin D Receptor complex with Sila-A,Danio rerio,2.2,P 65 2 2,Hexagonal,65.457,65.457,262.257,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,45.94,,
9GYA,Vitamin D Receptor in complex with Sila-e,Danio rerio,1.85,P 65 2 2,Hexagonal,65.92,65.92,263.57,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.96,,
9GYC,Vitamin D receptor in complex with Sila-d,Danio rerio,2.2,P 65 2 2,Hexagonal,65.914,65.914,262.944,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.83,,
9GYJ,Vitamin D receptor in complex with Sila-c,Danio rerio,1.9,P 65 2 2,Hexagonal,65.745,65.745,262.744,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.51,,
9GYK,Vitamin D receptor in complex with Sila-f,Danio rerio,2.2,P 65 2 2,Hexagonal,65.95,65.95,264.41,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.18,,
6T2M,VDR-ZK168281 complex,Danio rerio,3.0,P 65 2 2,Hexagonal,66.155,66.155,265.315,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,57.84,,
7OXZ,VDR complex with a side-chain hydroxylated derivative of lithocholic acid,Danio rerio,2.2,P 65 2 2,Hexagonal,66.38,66.38,263.186,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.33,,
7OY4,VDR complex of a side-chain hydroxylated derivatives of lithocholic acid,Danio rerio,2.0,P 65 2 2,Hexagonal,66.489,66.489,263.846,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,290.0,,47.64,,
3CS4,Structure-based design of a superagonist ligand for the vitamin D nuclear receptor,Homo sapiens,2.0,P 21 21 21,Orthorhombic,45.007,51.37,132.236,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,52.04,,
3CS6,Structure-based design of a superagonist ligand for the vitamin D nuclear receptor,Homo sapiens,1.8,P 21 21 21,Orthorhombic,45.055,51.458,132.132,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,52.13,,
3M7R,Crystal structure of VDR H305Q mutant,Homo sapiens,1.8,P 21 21 21,Orthorhombic,44.402,51.67,131.888,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,53.27,,
4G2I,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Homo sapiens,1.8,P 21 21 21,Orthorhombic,44.741,51.449,132.427,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,52.56,,
5GT4,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2S,3R,5Z,7E,14beta,17alpha)-2-cyanopropoxy-9,10-secocholesta-5,7,10-triene-1,3,25-triol",Homo sapiens,1.83,P 21 21 21,Orthorhombic,44.663,51.842,131.475,90.0,90.0,90.0,EVAPORATION,,277.0,,53.21,,
8IQN,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 24,24-F2-25(OH)D3",Homo sapiens,1.639,P 21 21 21,Orthorhombic,45.02,51.434,132.375,90.0,90.0,90.0,VAPOR DIFFUSION,,293.0,,44.78,,
8IQT,Crystal structure of the human vitamin D receptor ligand binding domain complexed with (23R)-F-25(OH)D3,Homo sapiens,1.745,P 21 21 21,Orthorhombic,44.723,51.363,132.102,90.0,90.0,90.0,VAPOR DIFFUSION,,293.0,,44.22,,
5XPL,"Crystal structure of VDR-LBD complexed with 22S-butyl-25-hydroxyphenyl-2-methylidene-19,26,27-trinor-25-oxo-1-hydroxyvitamin D3",Rattus norvegicus,2.05,C 1 2 1,Monoclinic,128.78,44.91,45.52,90.0,93.62,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,39.72,,
1TXI,Crystal structure of the vdr ligand binding domain complexed to TX522,Homo sapiens,1.9,P 21 21 21,Orthorhombic,45.259,52.504,132.93,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,47.0,,
2HAM,Crystal structure of VDR LBD complexed to 2alpha-propyl-calcitriol,Homo sapiens,1.9,P 21 21 21,Orthorhombic,45.06,51.326,131.304,90.0,90.0,90.0,"VAPOR DIFFUSION, SITTING DROP",,277.0,,53.26,,
2HAR,Crystal structure of VDR LBD in complex with 2 alpha-(3-hydroxy-1-propoxy) calcitriol,Homo sapiens,1.9,P 21 21 21,Orthorhombic,45.118,51.318,131.284,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.31,,
2HAS,Crystal structure of VDR LBD in complex with 2alpha-(1-propoxy) calcitriol,Homo sapiens,1.96,P 21 21 21,Orthorhombic,45.1,51.669,131.715,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.76,,
2HB7,Crystal structure of VDR LBD in complex with 2alpha(3-hydroxy-1-propyl) calcitriol,Homo sapiens,1.8,P 21 21 21,Orthorhombic,44.981,51.368,132.201,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.54,,
2HB8,Crystal structure of VDR LBD in complex with 2alpha-methyl calcitriol,Homo sapiens,2.0,P 21 21 21,Orthorhombic,44.99,51.56,132.21,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.72,,
3A2I,Crystal structure of the human vitamin D receptor (H305F) ligand binding domain complexed with TEI-9647,Homo sapiens,3.27,P 21 21 21,Orthorhombic,44.796,51.365,131.773,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,51.62,,
3A2J,Crystal structure of the human vitamin D receptor (H305F/H397F) ligand binding domain complexed with TEI-9647,Homo sapiens,2.7,P 21 21 21,Orthorhombic,44.687,51.393,131.846,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,51.54,,
3AUQ,Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2alpha-methyl-19-norvitamin D3,Homo sapiens,2.64,P 21 21 21,Orthorhombic,44.313,52.108,132.577,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,52.1,,
3AUR,Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2beta-methyl-19-norvitamin D3,Homo sapiens,2.21,P 21 21 21,Orthorhombic,44.279,51.44,131.985,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,51.22,,
3AX8,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 15alpha-methoxy-1alpha,25-dihydroxyvitamin D3",Homo sapiens,2.6,P 21 21 21,Orthorhombic,44.489,51.585,132.017,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,51.6,,
3AZ1,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.5,P 21 21 21,Orthorhombic,44.613,51.732,131.579,90.0,90.0,90.0,hanging drop,,277.0,,53.43,,
3AZ2,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.69,P 21 21 21,Orthorhombic,44.53,51.84,132.4,90.0,90.0,90.0,hanging drop,,,,53.73,,
3AZ3,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.36,P 21 21 21,Orthorhombic,44.32,52.222,131.946,90.0,90.0,90.0,hanging drop,,,,53.69,,
3O1D,"Structure-function study of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.",Danio rerio,2.4007,P 65 2 2,Hexagonal,66.108,66.108,264.64,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,297.0,,47.48,,
3O1E,"Structure-function of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.",Danio rerio,2.5001,P 65 2 2,Hexagonal,65.842,65.842,263.718,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,297.0,,46.87,,
3P8X,"Synthesis, Structure, and Biological Activity of des-Side Chain Analogues of 1alpha,25-Dihydroxyvitamin D3 with Substituents at C-18",Homo sapiens,1.7,P 21 21 21,Orthorhombic,44.628,51.342,130.82,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,48.09,,
3VHW,Crystal structure of the human vitamin D receptor ligand binding domain complexed with 4-MP,Homo sapiens,2.43,P 21 21 21,Orthorhombic,44.975,51.47,131.264,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,51.74,,
3W0A,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.8,P 21 21 21,Orthorhombic,44.619,51.803,132.513,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,,,53.82,,
3W0C,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.9,P 21 21 21,Orthorhombic,44.37,51.917,132.087,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.52,,
3W0Y,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.98,P 21 21 21,Orthorhombic,45.217,51.124,132.664,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.88,,
3WWR,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1-((((1S,2R,6R,Z)-2,6-dihydroxy-4-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-3-methylenecyclohexyl)oxy)methyl)cyclopropanecarbonitrile",Homo sapiens,3.18,P 21 21 21,Orthorhombic,45.167,51.826,132.384,90.0,90.0,90.0,VAPOR DIFFUSION,,293.0,,52.68,,
3X31,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 7,8-cis-14-epi-1a,25-Dihydroxy-19-norvitamin D3",Homo sapiens,2.11,P 21 21 21,Orthorhombic,44.369,51.508,131.52,90.0,90.0,90.0,VAPOR DIFFUSION,,293.0,,51.21,,
3X36,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 7,8-cis-1a,25-Dihydroxy-19-norvitamin D3",Homo sapiens,1.93,P 21 21 21,Orthorhombic,44.819,51.27,132.166,90.0,90.0,90.0,VAPOR DIFFUSION,,293.0,,51.71,,
4FHH,Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition,Danio rerio,2.33,P 65 2 2,Hexagonal,66.289,66.289,264.225,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,291.0,,47.89,,
4ITE,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(2H-tetrazol-2-yl)ethyl]vitamin D3",Homo sapiens,2.49,P 21 21 21,Orthorhombic,44.76,51.531,131.781,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,51.76,,
4ITF,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(1H-tetrazole-1-yl)ethyl]vitamin D3",Homo sapiens,2.84,P 21 21 21,Orthorhombic,44.353,51.809,132.08,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,51.68,,
4Q0A,Vitamin D Receptor complex with lithocholic acid,Danio rerio,1.9,P 65 2 2,Hexagonal,66.213,66.213,262.571,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,290.0,,47.75,,
4RUO,Crystal structure of zVDR L337H mutant-gemini complex,Danio rerio,2.805,P 65 2 2,Hexagonal,66.085,66.085,265.233,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,47.52,,
5LGA,"Structural analysis and biological activities of BXL0124, a Gemini analog of Vitamin D",Danio rerio,2.5,P 65 2 2,Hexagonal,65.86,65.86,263.83,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,297.0,,47.13,,
8P9X,Vitamin D receptor complex with Xe4Me agonist ligand,Danio rerio,2.15,P 65 2 2,Hexagonal,65.827,65.827,264.258,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.95,,
7QPI,"Structure of lamprey VDR in complex with 1,25D3",Petromyzon marinus,2.5,P 21 21 21,Orthorhombic,37.32,66.17,105.69,90.0,90.0,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,35.91,,
7OXU,VDR complex - calcitroic acid,Danio rerio,2.39,P 65 2 2,Hexagonal,65.728,65.728,264.354,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,49.47,,
4G1D,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.9,P 65 2 2,Hexagonal,66.287,66.287,263.662,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,47.78,,
4G1Y,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.85,P 65 2 2,Hexagonal,65.559,65.559,263.876,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,46.36,,
4G1Z,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.5,P 65 2 2,Hexagonal,66.472,66.472,262.336,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,47.52,,
4G20,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.9,P 65 2 2,Hexagonal,66.497,66.497,262.551,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,47.6,,
4G21,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.9,P 65 2 2,Hexagonal,66.287,66.287,263.662,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,47.49,,
4G2H,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.5,P 65 2 2,Hexagonal,66.438,66.438,265.761,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,48.14,,
5E7V,Potent Vitamin D Receptor Agonist,Danio rerio,2.4,P 65 2 2,Hexagonal,66.49,66.49,263.34,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,295.0,,47.75,,
5MX7,"1a,20S-dihydroxyvitamin D3 VDR complex",Danio rerio,1.98,P 65 2 2,Hexagonal,65.936,65.936,262.97,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,295.0,,46.79,,
5OW7,VDR complex,Danio rerio,2.1,P 65 2 2,Hexagonal,65.699,65.699,262.259,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,298.0,,46.04,,
7BNS,VDR complex with BXL-62,Danio rerio,2.7,P 65 2 2,Hexagonal,65.874,65.874,263.683,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,273.0,,46.62,,
7BNU,VDR complex with BXL-62,Danio rerio,2.4,P 65 2 2,Hexagonal,65.658,65.658,264.139,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,273.0,,46.32,,
7BO6,VDR complex with LCA derivative,Danio rerio,2.86,P 65 2 2,Hexagonal,66.39,66.39,263.82,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.47,,
7ZFG,VDR complex with aromatic D-ring analog,Danio rerio,2.62,P 65 2 2,Hexagonal,65.83,65.83,264.92,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.8,,
7ZFX,VDR complex with Aromatic-D-Ring Analog,Danio rerio,2.6,P 65 2 2,Hexagonal,65.723,65.723,263.897,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,47.1,,
8CK5,"VDR LBD complex with 25-nitro derivative of 1,25D3",Danio rerio,2.1,P 65 2 2,Hexagonal,65.701,65.701,262.106,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.02,,
9EYR,VDR complex with gemini analog UG-480,Danio rerio,2.56,P 65 2 2,Hexagonal,65.67,65.67,263.73,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.3,,
9FBF,VDR complex with UG-481,Danio rerio,3.01,P 65 2 2,Hexagonal,65.54,65.54,262.95,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,45.92,,
2ZL9,"2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure",Rattus norvegicus,1.9,C 1 2 1,Monoclinic,153.902,42.32,42.13,90.0,95.67,90.0,"VAPOR DIFFUSION, HANGING DROP",,,,42.04,,
2ZLA,"2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure",Rattus norvegicus,2.0,C 1 2 1,Monoclinic,153.985,42.002,42.152,90.0,95.77,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.65,,
2ZLC,"2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure",Rattus norvegicus,2.0,C 1 2 1,Monoclinic,153.859,41.998,41.951,90.0,96.06,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.29,,
3VT4,Crystal structures of rat VDR-LBD with R270L mutation,Rattus norvegicus,1.9,C 1 2 1,Monoclinic,153.725,41.865,42.217,90.0,95.92,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.52,,
3VT5,Crystal structures of rat VDR-LBD with R270L mutation,Rattus norvegicus,2.11,C 1 2 1,Monoclinic,153.174,42.565,42.184,90.0,96.1,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.21,,
3VT6,"Crystal structure of rat VDR-LBD with 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3",Rattus norvegicus,2.3,C 1 2 1,Monoclinic,153.734,42.724,42.271,90.0,95.55,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.73,,
3VT8,Crystal structures of rat VDR-LBD with W282R mutation,Rattus norvegicus,2.1,C 1 2 1,Monoclinic,155.068,42.052,41.868,90.0,95.62,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.81,,
3VT9,Crystal structures of rat VDR-LBD with W282R mutation,Rattus norvegicus,2.35,C 1 2 1,Monoclinic,154.714,42.05,41.972,90.0,95.63,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.81,,
3A3Z,Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277A(C23S),Homo sapiens,1.72,P 21 21 21,Orthorhombic,45.297,51.688,133.092,90.0,90.0,90.0,"VAPOR DIFFUSION, SITTING DROP",,277.0,,52.94,,
3A40,Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277B(C23R),Homo sapiens,1.45,P 21 21 21,Orthorhombic,44.969,51.496,131.91,90.0,90.0,90.0,"VAPOR DIFFUSION, SITTING DROP",,277.0,,51.99,,
3KPZ,"Crystal structure of a novel vitamin D3 analogue, ZK203278 showing dissociated profile",Homo sapiens,1.9,P 21 21 21,Orthorhombic,44.887,51.892,132.204,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,273.0,,54.07,,
3OGT,"Design, Chemical synthesis, Functional characterization and Crystal structure of the sidechain analogue of 1,25-dihydroxyvitamin D3.",Homo sapiens,1.75,P 21 21 21,Orthorhombic,45.018,51.622,132.818,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.15,,
3TKC,"Design, Synthesis, Evaluation and Structure of Vitamin D Analogues with Furan Side Chains",Homo sapiens,1.75,P 21 21 21,Orthorhombic,45.018,51.622,132.818,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,53.15,,
3WGP,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,2.0,P 21 21 21,Orthorhombic,44.82,51.39,131.64,90.0,90.0,90.0,,,,,53.35,,
3AFR,"Crystal Structure of VDR-LBD/22S-Butyl-1a,24R-dihydroxyvitamin D3 complex",Rattus norvegicus,2.0,C 1 2 1,Monoclinic,153.448,43.394,41.992,90.0,95.341,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.15,,
3VT3,Crystal structures of rat VDR-LBD with R270L mutation,Rattus norvegicus,1.7,C 1 2 1,Monoclinic,153.883,41.626,41.956,90.0,96.31,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,40.84,,
1IE8,Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to KH1060,Homo sapiens,1.52,P 21 21 21,Orthorhombic,44.49,51.87,131.39,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,52.28,,
1IE9,Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to MC1288,Homo sapiens,1.4,P 21 21 21,Orthorhombic,44.94,51.42,132.52,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,277.0,,52.75,,
3A78,"Crystal structure of the human VDR ligand binding domain bound to the natural metabolite 1alpha,25-dihydroxy-3-epi-vitamin D3",Homo sapiens,1.9,P 21 21 21,Orthorhombic,44.889,51.12,132.196,90.0,90.0,90.0,"VAPOR DIFFUSION, SITTING DROP",,277.0,,51.66,,
3DR1,Side-chain fluorine atoms of non-steroidal vitamin D3 analogs stabilize helix 12 of vitamin D receptor,Danio rerio,2.7,P 65 2 2,Hexagonal,66.1,66.1,265.6,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,298.0,,47.37,,
4RUJ,Crystal structure of zVDR L337H mutant-VD complex,Danio rerio,2.352,P 65 2 2,Hexagonal,65.851,65.851,264.373,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,297.0,,46.69,,
4RUP,Crystal structure of zVDR L337H mutant-Gemini72 complex,Danio rerio,2.75,P 65 2 2,Hexagonal,65.741,65.741,263.851,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,46.4,,
5NKY,Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain,Danio rerio,2.096,P 65 2 2,Hexagonal,66.191,66.191,261.698,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,290.0,,46.73,,
5NMA,Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain,Danio rerio,2.8,P 65 2 2,Hexagonal,66.175,66.175,262.859,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,290.0,,46.94,,
5NMB,Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain,Danio rerio,2.5,P 65 2 2,Hexagonal,65.893,65.893,262.598,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,290.0,,46.43,,
5OW9,Vitamin D receptor complex,Danio rerio,2.403,P 65 2 2,Hexagonal,65.98,65.98,262.87,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,298.0,,46.63,,
5OWD,Vitamin D receptor complex,Danio rerio,2.151,P 65 2 2,Hexagonal,65.75,65.75,262.97,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,298.0,,46.27,,
6FO7,Vitamin D nuclear receptor complex 3,Danio rerio,2.59,P 65 2 2,Hexagonal,66.25,66.25,262.9,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,295.0,,47.28,,
6FO8,Vitamin D nuclear receptor complex 4,Danio rerio,2.3,P 65 2 2,Hexagonal,66.69,66.69,264.52,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,295.0,,48.29,,
6FO9,Vitamin D nuclear receptor complex 2,Danio rerio,2.701,P 65 2 2,Hexagonal,66.01,66.01,264.46,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,295.0,,47.21,,
6FOB,Vitamin D receptor complex 5,Danio rerio,2.75,P 65 2 2,Hexagonal,66.22,66.22,264.2,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,295.0,,47.49,,
6FOD,Vitamin D nuclear receptor complex 1,Danio rerio,2.5,P 65 2 2,Hexagonal,65.93,65.93,264.2,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,295.0,,47.03,,
7B39,Allene-Based Design of a Noncalcemic Vitamin D Receptor Agonist,Danio rerio,2.13,P 65 2 2,Hexagonal,66.25,66.25,264.39,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,57.51,,
8CKC,"Vitamin D receptor complex with 25-amine derivative of 1,25D3",Danio rerio,2.1,P 65 2 2,Hexagonal,65.736,65.736,263.11,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.31,,
8P9W,vitamin D receptor complex with Xe4MeCF3 analog,Danio rerio,2.9,P 65 2 2,Hexagonal,65.82,65.82,263.22,90.0,90.0,120.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,46.44,,
5XPM,"Crystal structure of VDR-LBD complexed with 22S-Butyl-25RS-(hydroxyphenyl)-25-methoxy-2-methylidene-19,26,27-trinor-1-hydroxyvitamin D3",Rattus norvegicus,2.2,C 1 2 1,Monoclinic,153.0,41.84,42.25,90.0,96.69,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.09,,
5XPN,"Crystal structure of VDR-LBD complexed with 25RS-(hydroxyphenyl)-25-methoxy-2-methylidene-19,26,27-trinor-1-hydroxyvitamin D3",Rattus norvegicus,1.96,C 1 2 1,Monoclinic,153.74,43.16,42.03,90.0,95.32,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.01,,
5XPO,"Crystal structure of VDR-LBD complexed with 25-(hydroxyphenyl)-2-methylidene-19,26,27-trinor-25-oxo-1-hydroxyvitamin D3",Rattus norvegicus,2.28,C 1 2 1,Monoclinic,153.56,43.39,42.13,90.0,95.48,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.36,,
5XPP,"Crystal structure of VDR-LBD complexed with 25RS-(Hydroxyphenyl)-2-methylidene-19,26,27-trinor-1,25-dihydroxyvitamin D3",Rattus norvegicus,2.85,C 1 2 1,Monoclinic,154.38,42.86,41.74,90.0,95.65,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.42,,
5H1E,Interaction between vitamin D receptor and coactivator peptide SRC2-3,Rattus norvegicus,2.6,C 1 2 1,Monoclinic,155.77,42.88,42.21,90.0,95.83,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.54,,
3VTB,Crystal structure of rat vitamin D receptor bound to a partial agonist 25-adamantyl-23-yne-19-norvitammin D ADTK1,Rattus norvegicus,2.0,C 1 2 1,Monoclinic,153.563,43.199,42.487,90.0,95.56,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.58,,
3VTC,Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin D ADTK3,Rattus norvegicus,1.5,C 1 2 1,Monoclinic,126.847,45.733,46.638,90.0,93.87,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.37,,
3VTD,Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin D ADTK4,Rattus norvegicus,2.7,C 1 2 1,Monoclinic,153.178,43.897,42.526,90.0,95.73,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,44.38,,
2ZMH,Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism,Rattus norvegicus,2.1,C 1 2 1,Monoclinic,154.643,42.334,42.066,90.0,95.47,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.27,,
2ZMJ,Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism,Rattus norvegicus,2.35,C 1 2 1,Monoclinic,153.73,43.242,41.953,90.0,95.5,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.99,,
2ZXM,A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket,Rattus norvegicus,3.01,C 1 2 1,Monoclinic,153.252,43.424,42.369,90.0,95.97,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.57,,
2ZXN,A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket,Rattus norvegicus,2.1,C 1 2 1,Monoclinic,153.158,43.879,41.886,90.0,95.89,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.48,,
3WTQ,"Crystal structure of VDR-LBD complexed with 22S-butyl-2-methylidene-19-nor-1a,25-dihydroxyvitamin D3",Rattus norvegicus,2.1,C 1 2 1,Monoclinic,152.286,43.851,42.321,90.0,96.18,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.68,,
5B41,"Crystal structure of VDR-LBD complexed with 2-methylidene-19-nor-1a,25-dihydroxyvitamin D3",Rattus norvegicus,1.89,C 1 2 1,Monoclinic,154.17,41.75,41.77,90.0,96.02,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,40.81,,
5B5B,"Crystal structure of VDR-LBD complexed with 2-methylidene-26,27-diphenyl-19-nor-1,25-dihydroxyvitamin D3",Rattus norvegicus,2.0,C 1 2 1,Monoclinic,154.06,41.49,83.89,90.0,97.44,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,40.47,,
5GIC,Crystal structure of VDR in complex with DLAM-2P,Rattus norvegicus,2.352,C 1 2 1,Monoclinic,154.315,42.444,42.106,90.0,96.53,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,49.15,,
5GID,Crystal structure of VDR in complex with DLAM-4 (C2 form),Rattus norvegicus,2.151,C 1 2 1,Monoclinic,154.51,42.345,42.32,90.0,96.46,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,49.33,,
5GIE,Crystal structure of VDR in complex with DLAM-4P (P21 form),Rattus norvegicus,2.387,P 1 21 1,Monoclinic,65.364,42.077,96.802,90.0,94.55,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,46.24,,
5XUQ,"Crystal structure of VDR-LBD complexed with an antagonist, 2-methylidene-19,26,27-trinor-22-(S)-butyl-1-hydroxy-25-oxo-25-(1H-pyrrol-2-yl)- vitamin D3",Rattus norvegicus,2.8,C 1 2 1,Monoclinic,151.8,41.49,42.02,90.0,96.97,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,39.76,,
2ZMI,Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism,Rattus norvegicus,1.7,C 1 2 1,Monoclinic,155.222,42.412,41.955,90.0,95.21,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.46,,
2HC4,Crystal structure of the LBD of VDR of Danio rerio in complex with calcitriol,Danio rerio,2.2,P 65 2 2,Hexagonal,65.835,65.835,264.839,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,298.0,,46.77,,
1DB1,CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D COMPLEXED TO VITAMIN D,Homo sapiens,1.8,P 21 21 21,Orthorhombic,45.193,52.443,133.286,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,298.0,,54.2,,
4FHI,Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition,Danio rerio,2.4,P 65 2 2,Hexagonal,66.3,66.3,264.509,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,291.0,,48.0,,
2O4J,Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20Z and the NR2 Box of DRIP 205,Rattus norvegicus,1.74,C 1 2 1,Monoclinic,155.5,42.4,41.9,90.0,96.5,90.0,macroseeding in batch,,295.0,,38.03,,
2O4R,Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20E and the NR2 Box of DRIP 205,Rattus norvegicus,1.98,C 1 2 1,Monoclinic,154.0,43.0,42.0,90.0,96.0,90.0,macroseeding in batch,,295.0,,38.5,,
4YNK,Crystal structure of vitamin D receptor ligand binding domain complexed with a 19-norvitamin D compound,Rattus norvegicus,2.3,C 1 2 1,Monoclinic,157.437,37.29,41.121,90.0,98.47,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.15,,33.6,,
5AWJ,Crystal structure of VDR-LBD/partial agonist complex: 22S-hexyl analogue,Rattus norvegicus,2.2,C 1 2 1,Monoclinic,153.477,43.447,42.317,90.0,100.53,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.95,,
5AWK,Crystal structure of VDR-LBD/partial agonist complex: 22S-ethyl analogue,Rattus norvegicus,2.9,C 1 2 1,Monoclinic,154.03,41.97,41.86,90.0,95.96,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.2,,
5ZWE,Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a vinyl ketone group via conjugate addition reaction,Rattus norvegicus,2.72,C 1 2 1,Monoclinic,153.53,42.44,41.87,90.0,95.98,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.67,,
5ZWF,Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a enone with a beta methyl group via conjugate addition reaction,Rattus norvegicus,2.1,C 1 2 1,Monoclinic,153.56,41.73,42.02,90.0,96.22,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,40.88,,
5ZWH,Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having an ene-ynone group via conjugate addition reaction,Rattus norvegicus,2.38,C 1 2 1,Monoclinic,154.3,42.52,41.96,90.0,95.72,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.23,,
5ZWI,Interaction between Vitamin D receptor (VDR) and a ligand having a dienone group,Rattus norvegicus,2.4,C 1 2 1,Monoclinic,153.67,42.4,41.85,90.0,95.96,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.65,,
6JEZ,Covalent labeling of rVDR-LBD by turn-on fluorescent probe mediated by conjugate addition and cyclization,Rattus norvegicus,2.3,C 1 2 1,Monoclinic,153.93,43.39,42.0,90.0,95.3,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.34,,
2ZFX,Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,1.99,P 21 21 2,Orthorhombic,44.188,136.344,47.29,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,,,45.39,,
3A2H,Crystal structure of the rat vitamin D receptor ligand binding domain complexed with TEI-9647 and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,2.5,C 1 2 1,Monoclinic,124.809,45.349,46.662,90.0,100.13,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,40.15,,
3VRT,"VDR ligand binding domain in complex with 2-Mehylidene-19,25,26,27-tetranor-1alpha,24-dihydroxyvitaminD3",Rattus norvegicus,2.4,C 1 2 1,Monoclinic,152.988,43.867,42.428,90.0,95.94,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,44.12,,
3VRU,"VDR ligand binding domain in complex with 2-Methylidene-19,24-dinor-1alpha,25-dihydroxy vitaminD3",Rattus norvegicus,2.0,C 1 2 1,Monoclinic,154.34,42.29,42.21,90.0,95.89,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.25,,
3VRV,"VDR ligand binding domain in complex with 2-Methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3",Rattus norvegicus,1.9,C 1 2 1,Monoclinic,154.14,42.77,42.12,90.0,95.42,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.75,,
3VRW,"VDR ligand binding domain in complex with 22S-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3",Rattus norvegicus,2.4,C 1 2 1,Monoclinic,154.21,43.21,42.38,90.0,95.49,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.7,,
3VT7,Crystal structures of rat VDR-LBD with W282R mutation,Rattus norvegicus,1.65,C 1 2 1,Monoclinic,155.143,42.281,41.846,90.0,95.53,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.13,,
3W0G,Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands,Rattus norvegicus,1.94,C 1 2 1,Monoclinic,154.303,41.975,42.05,90.0,94.86,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,45.02,,
3W0H,Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands,Rattus norvegicus,1.8,C 1 2 1,Monoclinic,124.643,45.059,47.156,90.0,100.36,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.71,,
3W0I,Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands,Rattus norvegicus,1.9,C 1 2 1,Monoclinic,154.143,42.733,42.39,90.0,94.7,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,46.38,,
3W0J,Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands,Rattus norvegicus,1.84,C 1 2 1,Monoclinic,154.214,42.39,42.144,90.0,94.89,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,45.64,,
3WT7,"Crystal structure of VDR-LBD complexed with 22R-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1 ,25-dihydroxyvitamin D3",Rattus norvegicus,2.4,C 1 2 1,Monoclinic,128.21,44.31,45.81,90.0,93.56,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,39.07,,
5XZF,Vitamin D receptor with a synthetic ligand ADRO1,Rattus norvegicus,2.1,C 1 2 1,Monoclinic,154.07,41.11,41.42,90.0,96.42,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,39.3,,
5XZH,Vitamin D receptor with a synthetic ligand ADRO2,Rattus norvegicus,2.0,C 1 2 1,Monoclinic,153.665,41.763,42.01,90.0,95.58,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,41.02,,
6K5O,Development of Novel Lithocholic Acid Derivatives as Vitamin D Receptor Agonists,Rattus norvegicus,1.8,C 1 2 1,Monoclinic,153.884,43.69,41.792,90.0,96.05,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.36,,
7C7V,Vitamin D3 receptor/lithochoric acid derivative complex,Rattus norvegicus,2.0,C 1 2 1,Monoclinic,158.045,36.898,39.486,90.0,96.963,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,30.76,,
7C7W,Vitamin D3 receptor/lithochoric acid derivative complex,Rattus norvegicus,1.9,C 1 2 1,Monoclinic,157.144,37.436,40.91,90.0,98.581,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,33.5,,
9M10,Vitamin D receptor complex with a dimethylbis((3-trifluoromethyl)phenyl)silane derivative,Rattus norvegicus,2.02,C 1 2 1,Monoclinic,127.16,43.01,45.59,90.0,93.314,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,36.42,,
9M11,Vitamin D receptor complex with a bis(3-chlorophenyl)dimethylsilane derivative,Rattus norvegicus,2.05,C 1 2 1,Monoclinic,152.59,45.15,42.36,90.0,98.46,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,45.18,,
9M12,Vitamin D receptor complex with a bis(3-ethylphenyl)dimethylsilane derivative,Rattus norvegicus,1.86,P 1 21 1,Monoclinic,45.89,44.98,128.71,90.0,94.819,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,40.22,,
9M13,Vitamin D receptor complex with a dimethyldiphenylsilane derivative,Rattus norvegicus,1.68,C 1 2 1,Monoclinic,124.699,44.798,46.786,90.0,100.186,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,38.48,,
9M14,Vitamin D receptor complex with a dimethyldi(m-tolyl)silane derivative,Rattus norvegicus,2.0,C 1 2 1,Monoclinic,153.61,44.75,42.37,90.0,95.729,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,45.39,,
9M15,Vitamin D receptor complex with a dimethyldi(o-tolyl)silane derivative,Rattus norvegicus,2.18,C 1 2 1,Monoclinic,152.66,44.67,42.06,90.0,95.83,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,44.54,,
9M16,"Vitamin D receptor complex with a bis(2,3-dimethylphenyl)dimethylsilane derivative",Rattus norvegicus,2.06,C 1 2 1,Monoclinic,154.612,42.568,42.271,90.0,95.56,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,42.85,,
9M17,"Vitamin D receptor complex with a bis(3,5-dimethylphenyl)dimethylsilane derivative",Rattus norvegicus,1.81,C 1 2 1,Monoclinic,151.71,44.84,42.19,90.0,96.748,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,44.47,,
9M18,Vitamin D receptor complex with a diallyldiphenylsilane derivative,Rattus norvegicus,1.96,C 1 2 1,Monoclinic,154.333,41.498,41.99,90.0,95.38,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,40.89,,
9M19,Vitamin D receptor complex with a dibutyldiphenylsilane derivative,Rattus norvegicus,2.05,C 1 2 1,Monoclinic,154.694,42.192,42.576,90.0,97.036,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,42.62,,
9M1A,Vitamin D receptor complex with a diethyldiphenylsilane derivative,Rattus norvegicus,1.78,C 1 2 1,Monoclinic,154.307,41.785,42.274,90.0,96.276,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,41.59,,
9M1B,Vitamin D receptor complex with a diphenydipropylsilane derivative,Rattus norvegicus,1.77,C 1 2 1,Monoclinic,154.79,42.37,42.28,90.0,96.375,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,42.57,,
9M1C,Vitamin D receptor complex with a triphenylpropylsilane derivative,Rattus norvegicus,1.67,C 1 2 1,Monoclinic,155.21,42.51,42.33,90.0,95.364,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,43.09,,
9M1D,Vitamin D receptor complex with a methyldiphenylpropylsilane derivative,Rattus norvegicus,1.44,C 1 2 1,Monoclinic,154.85,42.21,42.25,90.0,95.831,90.0,"VAPOR DIFFUSION, SITTING DROP",,293.0,,42.39,,
2HBH,Crystal structure of Vitamin D nuclear receptor ligand binding domain bound to a locked side-chain analog of calcitriol and SRC-1 peptide,Danio rerio,2.65,P 65 2 2,Hexagonal,65.682,65.682,265.096,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,298.0,,46.57,,
2HCD,Crystal structure of the ligand binding domain of the Vitamin D nuclear receptor in complex with Gemini and a coactivator peptide,Danio rerio,2.6,P 65 2 2,Hexagonal,65.859,65.859,265.018,90.0,90.0,120.0,"VAPOR DIFFUSION, HANGING DROP",,298.0,,46.84,,
1RJK,crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MD and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,1.99,C 1 2 1,Monoclinic,154.6,43.292,41.848,90.0,96.07,90.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,38.93,,
1RK3,"crystal structure of the rat vitamin D receptor ligand binding domain complexed with 1,25-dihydroxyvitamin D3 and a synthetic peptide containing the NR2 box of DRIP 205",Rattus norvegicus,2.2,C 1 2 1,Monoclinic,154.726,44.154,42.072,90.0,96.13,90.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,40.48,,
1RKG,crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MbisP and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,1.9,C 1 2 1,Monoclinic,154.447,44.114,41.86,90.0,96.62,90.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,39.96,,
1RKH,crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2AM20R and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,2.28,C 1 2 1,Monoclinic,154.8,42.291,41.788,90.0,96.15,90.0,"VAPOR DIFFUSION, HANGING DROP",,295.0,,37.46,,
3VJS,Vitamin D receptor complex with a carborane compound,Rattus norvegicus,1.93,C 1 2 1,Monoclinic,154.605,43.292,42.085,90.0,95.28,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,43.58,,
3VJT,Vitamin D receptor complex with a carborane compound,Rattus norvegicus,2.0,C 1 2 1,Monoclinic,154.855,42.319,42.176,90.0,95.59,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,42.47,,
3W5P,Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives,Rattus norvegicus,1.9,C 1 2 1,Monoclinic,154.509,42.371,41.649,90.0,96.79,90.0,"VAPOR DIFFUSION, HANGING DROP",,291.5,,41.55,,
3W5Q,Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives,Rattus norvegicus,1.9,C 1 2 1,Monoclinic,153.799,42.339,41.546,90.0,96.38,90.0,"VAPOR DIFFUSION, HANGING DROP",,291.5,,41.14,,
3W5R,Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives,Rattus norvegicus,2.2,C 1 2 1,Monoclinic,154.433,42.026,41.514,90.0,96.25,90.0,"VAPOR DIFFUSION, HANGING DROP",,291.5,,40.91,,
3W5T,Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives,Rattus norvegicus,2.29,C 1 2 1,Monoclinic,154.485,41.791,41.63,90.0,96.32,90.0,"VAPOR DIFFUSION, HANGING DROP",,291.5,,40.76,,
3WT5,A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: Active vitamin D analogues with 22R-alkyl group,Rattus norvegicus,1.9,C 1 2 1,Monoclinic,127.84,44.81,46.06,90.0,93.57,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,39.9,,
3WT6,A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: Active vitamin D analogues with 22R-alkyl group,Rattus norvegicus,2.0,C 1 2 1,Monoclinic,127.05,44.77,45.11,90.0,94.2,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,38.16,,
3AUN,Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR335 and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,1.81,P 21 21 2,Orthorhombic,44.237,136.521,47.334,90.0,90.0,90.0,"VAPOR DIFFUSION, HANGING DROP",,293.0,,45.57,,
7VQP,Vitamin D receptor complexed with a lithocholic acid derivative,Rattus norvegicus,1.94,C 1 2 1,Monoclinic,157.805,37.581,40.913,90.0,98.59,90.0,"VAPOR DIFFUSION, HANGING DROP",,297.0,,34.04,,
